TUDOR INVESTMENT CORP ET AL Global Blood Therapeutics, Inc. Transaction History

TUDOR INVESTMENT CORP ET AL portfolio value:

$17.03M
portfolio value

TUDOR INVESTMENT CORP ET AL quarter portfolio value change:

+113.15%
quarter

Global Blood Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +437.10% 203.52K shares 15.54M $68.1 250.09K
Q2 2022 share Increase +257.43% 33.53K shares 1.03M $31.95 46.56K
Q1 2022 share Decrease -77.52% -44.91K shares -1.24M $34.64 13.02K
Q4 2021 share Decrease -34.40% -30.39K shares -555K $29.86 57.94K
Q3 2021 share Increase 0.00% 88.33K shares 2.25M $25.48 88.33K
Q2 2018 share Decrease -100.00% -5.99K shares -289K $45.2 0
Q1 2018 share Decrease -30.06% -2.57K shares -48K $48.3 5.99K
Q4 2017 share Decrease -8.79% -825 shares 45K $39.35 8.56K
Q3 2017 share Decrease -56.74% -12.31K shares -302K $31.05 9.39K
Q2 2017 share Increase 0.00% 21.70K shares 594K $27.35 21.70K
Q3 2016 share Decrease -100.00% -26.24K shares -435K $23.05 0
Q2 2016 share Increase 0.00% 26.24K shares 435K $16.59 26.24K